[
  {
    "title": "Bristol Myers to Buy MyoKardia to Aid Cardiovascular Franchise - Yahoo Finance",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Bristol Myers to Buy MyoKardia to Aid Cardiovascular Franchise - Yahoo Finance"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://finance.yahoo.com/news/bristol-myers-buy-myokardia-aid-155903214.html"
      }
    ],
    "link": "https://finance.yahoo.com/news/bristol-myers-buy-myokardia-aid-155903214.html",
    "id": "52781102840921",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 15:59:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      15,
      59,
      0,
      0,
      279,
      0
    ],
    "summary": "<ol><li><a href=\"https://finance.yahoo.com/news/bristol-myers-buy-myokardia-aid-155903214.html\" target=\"_blank\">Bristol Myers to Buy MyoKardia to Aid Cardiovascular Franchise</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font></li><li><a href=\"https://www.morningstar.com/news/dow-jones/202010055939/myokardia-shares-rise-after-news-of-bristol-myers-squibb-deal\" target=\"_blank\">MyoKardia Shares Rise After News of Bristol Myers Squibb Deal</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Morningstar.com</font></li><li><a href=\"https://xconomy.com/new-york/2020/10/05/bristol-myers-to-buy-myokardia-fda-ready-heart-disease-drug-for-13-1b/\" target=\"_blank\">Bristol Myers to Buy MyoKardia, FDA-Ready Heart Disease Drug for $13.1B</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Xconomy</font></li><li><a href=\"https://www.financialbuzz.com/bristol-myers-set-to-acquire-myokardia-for-13-billion/\" target=\"_blank\">Bristol-Myers Set to Acquire MyoKardia for $13 Billion</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Financialbuzz.com</font></li><li><a href=\"https://www.cityam.com/bristol-myers-squibb-to-buy-heart-drugmaker-myokardia-for-13-1bn/\" target=\"_blank\">Bristol-Myers Squibb to buy heart drugmaker MyoKardia for $13.1bn</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">City A.M.</font></li><li><strong><a href=\"https://news.google.com/stories/CAAqOQgKIjNDQklTSURvSmMzUnZjbmt0TXpZd1NoTUtFUWpaLUlyM2tJQU1FZE05UzBGc196cHdLQUFQAQ?oc=5\" target=\"_blank\">View Full Coverage on Google News</a></strong></li></ol>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<ol><li><a href=\"https://finance.yahoo.com/news/bristol-myers-buy-myokardia-aid-155903214.html\" target=\"_blank\">Bristol Myers to Buy MyoKardia to Aid Cardiovascular Franchise</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font></li><li><a href=\"https://www.morningstar.com/news/dow-jones/202010055939/myokardia-shares-rise-after-news-of-bristol-myers-squibb-deal\" target=\"_blank\">MyoKardia Shares Rise After News of Bristol Myers Squibb Deal</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Morningstar.com</font></li><li><a href=\"https://xconomy.com/new-york/2020/10/05/bristol-myers-to-buy-myokardia-fda-ready-heart-disease-drug-for-13-1b/\" target=\"_blank\">Bristol Myers to Buy MyoKardia, FDA-Ready Heart Disease Drug for $13.1B</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Xconomy</font></li><li><a href=\"https://www.financialbuzz.com/bristol-myers-set-to-acquire-myokardia-for-13-billion/\" target=\"_blank\">Bristol-Myers Set to Acquire MyoKardia for $13 Billion</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Financialbuzz.com</font></li><li><a href=\"https://www.cityam.com/bristol-myers-squibb-to-buy-heart-drugmaker-myokardia-for-13-1bn/\" target=\"_blank\">Bristol-Myers Squibb to buy heart drugmaker MyoKardia for $13.1bn</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">City A.M.</font></li><li><strong><a href=\"https://news.google.com/stories/CAAqOQgKIjNDQklTSURvSmMzUnZjbmt0TXpZd1NoTUtFUWpaLUlyM2tJQU1FZE05UzBGc196cHdLQUFQAQ?oc=5\" target=\"_blank\">View Full Coverage on Google News</a></strong></li></ol>"
    },
    "source": {
      "href": "https://finance.yahoo.com",
      "title": "Yahoo Finance"
    },
    "sub_articles": [
      {
        "url": "https://finance.yahoo.com/news/bristol-myers-buy-myokardia-aid-155903214.html",
        "title": "Bristol Myers to Buy MyoKardia to Aid Cardiovascular Franchise",
        "publisher": "Yahoo Finance"
      },
      {
        "url": "https://www.morningstar.com/news/dow-jones/202010055939/myokardia-shares-rise-after-news-of-bristol-myers-squibb-deal",
        "title": "MyoKardia Shares Rise After News of Bristol Myers Squibb Deal",
        "publisher": "Morningstar.com"
      },
      {
        "url": "https://xconomy.com/new-york/2020/10/05/bristol-myers-to-buy-myokardia-fda-ready-heart-disease-drug-for-13-1b/",
        "title": "Bristol Myers to Buy MyoKardia, FDA-Ready Heart Disease Drug for $13.1B",
        "publisher": "Xconomy"
      },
      {
        "url": "https://www.financialbuzz.com/bristol-myers-set-to-acquire-myokardia-for-13-billion/",
        "title": "Bristol-Myers Set to Acquire MyoKardia for $13 Billion",
        "publisher": "Financialbuzz.com"
      },
      {
        "url": "https://www.cityam.com/bristol-myers-squibb-to-buy-heart-drugmaker-myokardia-for-13-1bn/",
        "title": "Bristol-Myers Squibb to buy heart drugmaker MyoKardia for $13.1bn",
        "publisher": "City A.M."
      }
    ]
  },
  {
    "title": "An in-depth look at the MyoKardia, Inc. (MYOK) stock - Marketing Sentinel",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "An in-depth look at the MyoKardia, Inc. (MYOK) stock - Marketing Sentinel"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://marketingsentinel.com/2020/10/05/an-in-depth-look-at-the-myokardia-inc-myok-stock/"
      }
    ],
    "link": "https://marketingsentinel.com/2020/10/05/an-in-depth-look-at-the-myokardia-inc-myok-stock/",
    "id": "CBMiWmh0dHBzOi8vbWFya2V0aW5nc2VudGluZWwuY29tLzIwMjAvMTAvMDUvYW4taW4tZGVwdGgtbG9vay1hdC10aGUtbXlva2FyZGlhLWluYy1teW9rLXN0b2NrL9IBXmh0dHBzOi8vbWFya2V0aW5nc2VudGluZWwuY29tLzIwMjAvMTAvMDUvYW4taW4tZGVwdGgtbG9vay1hdC10aGUtbXlva2FyZGlhLWluYy1teW9rLXN0b2NrL2FtcC8",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 16:01:36 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      16,
      1,
      36,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://marketingsentinel.com/2020/10/05/an-in-depth-look-at-the-myokardia-inc-myok-stock/\" target=\"_blank\">An in-depth look at the MyoKardia, Inc. (MYOK) stock</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Marketing Sentinel</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://marketingsentinel.com/2020/10/05/an-in-depth-look-at-the-myokardia-inc-myok-stock/\" target=\"_blank\">An in-depth look at the MyoKardia, Inc. (MYOK) stock</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Marketing Sentinel</font>"
    },
    "source": {
      "href": "https://marketingsentinel.com",
      "title": "Marketing Sentinel"
    },
    "sub_articles": []
  },
  {
    "title": "Stocks making the biggest moves midday: Regeneron, CrowdStrike, AMC Entertainment and more - CNBC",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Stocks making the biggest moves midday: Regeneron, CrowdStrike, AMC Entertainment and more - CNBC"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.cnbc.com/2020/10/05/stocks-making-the-biggest-moves-midday-regeneron-crowdstrike-amc-entertainment.html"
      }
    ],
    "link": "https://www.cnbc.com/2020/10/05/stocks-making-the-biggest-moves-midday-regeneron-crowdstrike-amc-entertainment.html",
    "id": "CAIiEH7FeruuZ1BbyColc-UmB44qGQgEKhAIACoHCAow2Nb3CjDivdcCMM_rngY",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 15:58:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      15,
      58,
      0,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.cnbc.com/2020/10/05/stocks-making-the-biggest-moves-midday-regeneron-crowdstrike-amc-entertainment.html\" target=\"_blank\">Stocks making the biggest moves midday: Regeneron, CrowdStrike, AMC Entertainment and more</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.cnbc.com/2020/10/05/stocks-making-the-biggest-moves-midday-regeneron-crowdstrike-amc-entertainment.html\" target=\"_blank\">Stocks making the biggest moves midday: Regeneron, CrowdStrike, AMC Entertainment and more</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font>"
    },
    "source": {
      "href": "https://www.cnbc.com",
      "title": "CNBC"
    },
    "sub_articles": []
  },
  {
    "title": "Bristol Myers to buy heart-drug maker MyoKardia for $13.1B - Yahoo Canada Finance",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Bristol Myers to buy heart-drug maker MyoKardia for $13.1B - Yahoo Canada Finance"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://ca.finance.yahoo.com/video/bristol-myers-buy-heart-drug-163816243.html"
      }
    ],
    "link": "https://ca.finance.yahoo.com/video/bristol-myers-buy-heart-drug-163816243.html",
    "id": "CBMiTmh0dHBzOi8vY2EuZmluYW5jZS55YWhvby5jb20vdmlkZW8vYnJpc3RvbC1teWVycy1idXktaGVhcnQtZHJ1Zy0xNjM4MTYyNDMuaHRtbNIBVmh0dHBzOi8vY2EuZmluYW5jZS55YWhvby5jb20vYW1waHRtbC92aWRlby9icmlzdG9sLW15ZXJzLWJ1eS1oZWFydC1kcnVnLTE2MzgxNjI0My5odG1s",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 16:38:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      16,
      38,
      0,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://ca.finance.yahoo.com/video/bristol-myers-buy-heart-drug-163816243.html\" target=\"_blank\">Bristol Myers to buy heart-drug maker MyoKardia for $13.1B</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Canada Finance</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://ca.finance.yahoo.com/video/bristol-myers-buy-heart-drug-163816243.html\" target=\"_blank\">Bristol Myers to buy heart-drug maker MyoKardia for $13.1B</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Canada Finance</font>"
    },
    "source": {
      "href": "https://ca.finance.yahoo.com",
      "title": "Yahoo Canada Finance"
    },
    "sub_articles": []
  },
  {
    "title": "Mid-Day Market Update: Crude Oil Jumps 7%; Nam Tai Property Shares Plunge - Benzinga",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Mid-Day Market Update: Crude Oil Jumps 7%; Nam Tai Property Shares Plunge - Benzinga"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.benzinga.com/m-a/20/10/17785993/mid-day-market-update-crude-oil-jumps-7-nam-tai-property-shares-plunge"
      }
    ],
    "link": "https://www.benzinga.com/m-a/20/10/17785993/mid-day-market-update-crude-oil-jumps-7-nam-tai-property-shares-plunge",
    "id": "CBMicmh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9tLWEvMjAvMTAvMTc3ODU5OTMvbWlkLWRheS1tYXJrZXQtdXBkYXRlLWNydWRlLW9pbC1qdW1wcy03LW5hbS10YWktcHJvcGVydHktc2hhcmVzLXBsdW5nZdIBAA",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 16:12:36 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      16,
      12,
      36,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.benzinga.com/m-a/20/10/17785993/mid-day-market-update-crude-oil-jumps-7-nam-tai-property-shares-plunge\" target=\"_blank\">Mid-Day Market Update: Crude Oil Jumps 7%; Nam Tai Property Shares Plunge</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Benzinga</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.benzinga.com/m-a/20/10/17785993/mid-day-market-update-crude-oil-jumps-7-nam-tai-property-shares-plunge\" target=\"_blank\">Mid-Day Market Update: Crude Oil Jumps 7%; Nam Tai Property Shares Plunge</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Benzinga</font>"
    },
    "source": {
      "href": "https://www.benzinga.com",
      "title": "Benzinga"
    },
    "sub_articles": []
  },
  {
    "title": "Stocks Advance on Optimism Over Trump's Health, Stimulus Hopes - TheStreet",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Stocks Advance on Optimism Over Trump's Health, Stimulus Hopes - TheStreet"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.thestreet.com/markets/stock-market-today-dow-jones-industrial-average-trump-covid-100520"
      }
    ],
    "link": "https://www.thestreet.com/markets/stock-market-today-dow-jones-industrial-average-trump-covid-100520",
    "id": "CAIiEIuzkxnKofJKgCp5Nk1LhGkqFQgEKg0IACoGCAow8_0FMPBXMNniAg",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 16:43:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      16,
      43,
      0,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.thestreet.com/markets/stock-market-today-dow-jones-industrial-average-trump-covid-100520\" target=\"_blank\">Stocks Advance on Optimism Over Trump's Health, Stimulus Hopes</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TheStreet</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.thestreet.com/markets/stock-market-today-dow-jones-industrial-average-trump-covid-100520\" target=\"_blank\">Stocks Advance on Optimism Over Trump's Health, Stimulus Hopes</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TheStreet</font>"
    },
    "source": {
      "href": "https://www.thestreet.com",
      "title": "TheStreet"
    },
    "sub_articles": []
  },
  {
    "title": "Major Indexes Extend Gains as Stimulus Optimism Builds - Schaeffers Research",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Major Indexes Extend Gains as Stimulus Optimism Builds - Schaeffers Research"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.schaeffersresearch.com/content/ezines/2020/10/05/major-indexes-extend-gains-as-stimulus-optimism-builds"
      }
    ],
    "link": "https://www.schaeffersresearch.com/content/ezines/2020/10/05/major-indexes-extend-gains-as-stimulus-optimism-builds",
    "id": "CBMic2h0dHBzOi8vd3d3LnNjaGFlZmZlcnNyZXNlYXJjaC5jb20vY29udGVudC9lemluZXMvMjAyMC8xMC8wNS9tYWpvci1pbmRleGVzLWV4dGVuZC1nYWlucy1hcy1zdGltdWx1cy1vcHRpbWlzbS1idWlsZHPSAQA",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 16:09:29 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      16,
      9,
      29,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.schaeffersresearch.com/content/ezines/2020/10/05/major-indexes-extend-gains-as-stimulus-optimism-builds\" target=\"_blank\">Major Indexes Extend Gains as Stimulus Optimism Builds</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Schaeffers Research</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.schaeffersresearch.com/content/ezines/2020/10/05/major-indexes-extend-gains-as-stimulus-optimism-builds\" target=\"_blank\">Major Indexes Extend Gains as Stimulus Optimism Builds</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Schaeffers Research</font>"
    },
    "source": {
      "href": "https://www.schaeffersresearch.com",
      "title": "Schaeffers Research"
    },
    "sub_articles": []
  },
  {
    "title": "Is Gilead Finally a Buy After Huge Drop? - TheStreet",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Is Gilead Finally a Buy After Huge Drop? - TheStreet"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.thestreet.com/investing/gilead-sciences-gild-pullback-trading-100520"
      }
    ],
    "link": "https://www.thestreet.com/investing/gilead-sciences-gild-pullback-trading-100520",
    "id": "CAIiEMW8ofTIZ2zuob2TdRI3su4qGQgEKhAIACoHCAowysWVCzCLqqsDMMbdxgY",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 16:15:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      16,
      15,
      0,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.thestreet.com/investing/gilead-sciences-gild-pullback-trading-100520\" target=\"_blank\">Is Gilead Finally a Buy After Huge Drop?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TheStreet</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.thestreet.com/investing/gilead-sciences-gild-pullback-trading-100520\" target=\"_blank\">Is Gilead Finally a Buy After Huge Drop?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TheStreet</font>"
    },
    "source": {
      "href": "https://www.thestreet.com",
      "title": "TheStreet"
    },
    "sub_articles": []
  },
  {
    "title": "Nasdaq 100 Back On the Path Towards 11600 As US President Trump Improves - InvestingCube",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Nasdaq 100 Back On the Path Towards 11600 As US President Trump Improves - InvestingCube"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.investingcube.com/nasdaq-100-back-on-the-path-towards-11600-as-us-president-trump-improves/"
      }
    ],
    "link": "https://www.investingcube.com/nasdaq-100-back-on-the-path-towards-11600-as-us-president-trump-improves/",
    "id": "CAIiEEcdapix3_ZUQlpVUNCYROQqMwgEKioIACIQXY4NW35PSvpaZy0dOMBYqSoUCAoiEF2ODVt-T0r6WmctHTjAWKkw05_JBg",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 16:25:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      16,
      25,
      0,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.investingcube.com/nasdaq-100-back-on-the-path-towards-11600-as-us-president-trump-improves/\" target=\"_blank\">Nasdaq 100 Back On the Path Towards 11600 As US President Trump Improves</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">InvestingCube</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.investingcube.com/nasdaq-100-back-on-the-path-towards-11600-as-us-president-trump-improves/\" target=\"_blank\">Nasdaq 100 Back On the Path Towards 11600 As US President Trump Improves</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">InvestingCube</font>"
    },
    "source": {
      "href": "https://www.investingcube.com",
      "title": "InvestingCube"
    },
    "sub_articles": []
  }
]